At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SXTP 60 degrees pharmaceuticals, Inc.
Closed 11-13 16:00:00 EST
0.9800
-0.0300
-2.97%
盘后0.9800
+0.00000.00%
18:51 EST
High1.05
Low0.9200
Vol23.87K
Open1.01
D1 Closing1.01
Amplitude12.51%
Mkt Cap1.82M
Tradable Cap1.45M
Total Shares1.86M
T/O22.87K
T/O Rate1.61%
Tradable Shares1.48M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
60 Degrees Pharmaceuticals Inc. Announces Arakoda® Promotional Pilot in Advance of Expanded U.S. Launch
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.